Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac Suppository for Prostate Biopsy Pain
NCT01939743Phase 2Completed
- Sponsor
- Aga Khan University
- Start
- Oct 2011
- Primary completion
- Sep 2012
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of diclofenac in prostate cancer (PCa) (2 arms), sponsored by Aga Khan University. Primary endpoint: Pain on visual analog score at 2 hours. Started Oct 2011; status: completed.
02
Drugs
diclofenac
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01939743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01939743.